Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M708008200 on March 6, 2008

J. Biol. Chem., Vol. 283, Issue 19, 13174-13184, May 9, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
283/19/13174    most recent
M708008200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oliveira, V.
Right arrow Articles by Abraham, R. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oliveira, V.
Right arrow Articles by Abraham, R. T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

A Protective Role for the Human SMG-1 Kinase against Tumor Necrosis Factor-{alpha}-induced Apoptosis*Formula

Vasco Oliveira{ddagger}1, William J. Romanow§, Christoph Geisen, Diane M. Otterness||, Frank Mercurio§, Hong Gang Wang{ddagger}, William S. Dalton{ddagger}, and Robert T. Abraham||2

From the {ddagger}Department of Experimental Therapeutics, H. Lee Moffitt Cancer Center & Research Institute, University of South Florida, Tampa, Florida 33612, the §Discovery Biology Group, Signal Pharmaceuticals, LLC, San Diego, California 92121, the Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, and ||The Burnham Institute for Medical Research, La Jolla, California 92038

The human suppressor of morphogenesis in genitalia-1 (hSMG-1) protein kinase plays dual roles in mRNA surveillance and genotoxic stress response pathways in human cells. Here, we report that small interfering RNA-mediated depletion of hSMG-1, but not ATM, ATR, hUpf1, or hUpf2, in human U2OS osteosarcoma cells markedly increases the magnitude and accelerates the rate of apoptosis induced by tumor necrosis factor-{alpha} (TNF{alpha}) stimulation. The increase in TNF{alpha}-mediated cell killing observed in hSMG-1-depleted cells is not related to the suppression of nonsense-mediated mRNA decay or to the inhibition of TNF{alpha}-induced NF-{kappa}B activation. Rather, we observed that loss of hSMG-1 accelerates the degradation of the long form of the FLICE-inhibitory protein (FLIPL), an inhibitor of death-inducing signaling complex-mediated caspase-8 activation, in TNF{alpha}-treated cells. These results suggest that hSMG-1 plays an important role in cell survival during TNF{alpha}-induced stress.


Received for publication, September 25, 2007 , and in revised form, February 5, 2008.

* This work was supported, in whole or in part, by National Institutes of Health Grants CA97950 and CA2 P30 CA076292-10. This work was also supported by the Ataxia-Telangiectasia Children's Project, Johnson & Johnson, Department of Defense Grant DAMD17-02-1-0730, and the Molecular Biology Core Facility at the H. Lee Moffitt Cancer Center & Research Institute. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1–S4.

1 Supported by a postdoctoral fellowship from the Portuguese Fundação para a Ciência e a Tecnologia (Grant SFRH/BPD/20773/2004).

2 To whom correspondence should be addressed: Dept. of Experimental Therapeutics and Interdisciplinary Oncology, H. Lee Moffitt Cancer Center & Research Instit., University of South Florida, 12902 Magnolia Dr., Tampa, FL 33612. Tel.: 813-745-4361; Fax: 813-745-4258; E-mail: william.dalton{at}moffitt.org.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
R.-Q. Chen, Q.-K. Yang, Y.-L. Chen, V. A. Oliveira, W. S. Dalton, C. Fearns, and J.-D. Lee
Kinome Sirna Screen Identifies SMG-1 as a Negative Regulator of Hypoxia-inducible Factor-1{alpha} in Hypoxia
J. Biol. Chem., June 19, 2009; 284(25): 16752 - 16758.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
A. Yamashita, N. Izumi, I. Kashima, T. Ohnishi, B. Saari, Y. Katsuhata, R. Muramatsu, T. Morita, A. Iwamatsu, T. Hachiya, et al.
SMG-8 and SMG-9, two novel subunits of the SMG-1 complex, regulate remodeling of the mRNA surveillance complex during nonsense-mediated mRNA decay
Genes & Dev., May 1, 2009; 23(9): 1091 - 1105.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement